drugset / Trial / NCT05253794

Effect of Colchicine on the Progression of Aortic Valve Stenosis - A Pilot Study

NCT05253794

Phase 2/3 Completed 24 enrolled Ottawa Heart Institute Research Corporation
RandomizedParallel-groupQuadruple-blindPrevention

Summary

COPAS pilot is a pilot single center double blinded randomized study to determine the effect of targeted anti-inflammation therapy using colchicine, on valvular calcification activity using imaging, i.e. aortic valvular NaF uptake. The current proposal uses a randomized design to evaluate the effect of colchicine vs. placebo on valvular calcification activity over 6 months measured using NaF PET

Timeline

Start
2022-07-01
Primary completion
2024-07-31
Completion
2025-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral

Indications